| Literature DB >> 32518480 |
Ju-Hee Lee1, Gangmi Kim2.
Abstract
BACKGROUND AND OBJECTIVES: Single-incision laparoscopic cholecystectomy (SILC) has become increasingly popular. Regarding the difficulties of SILC in acute cholecystitis, additional port insertion is sometimes required. However, appropriate locations for additional port insertion have not been well studied. In the present study, the safety and effectiveness of the first additional port insertion in the epigastric region during SILC was assessed.Entities:
Keywords: Acute cholecystitis; Additional port; Single-incision laparoscopic cholecystectomy
Mesh:
Year: 2020 PMID: 32518480 PMCID: PMC7254861 DOI: 10.4293/JSLS.2020.00024
Source DB: PubMed Journal: JSLS ISSN: 1086-8089 Impact factor: 2.172
Patient Demographics and Clinical Characteristics
| Pure SILC | SILC with Additional Port | ||
|---|---|---|---|
| n | 61 | 52 | |
| Mean age (year ± SD) | 53.3 ± 13.4 | 61.8 ± 16.4 | .003 |
| Sex ratio | .332 | ||
| Male | 32 (52.5 %) | 32 (61.5 %) | |
| Female | 29 (47.5 %) | 20 (38.5 %) | |
| Mean BMI (kg/m2), range | 25.1 ± 4.1 | 24.9 ± 3.4 | .706 |
| Comorbid diseases | .055 | ||
| None | 38 (62.3 %) | 23 (44.2 %) | |
| ≥ 1 | 23 (37.7%) | 29 (55.8 %) | |
| ASA score | .036 | ||
| 1 | 19 (31.1%) | 11 (21.2%) | |
| 2 | 35 (57.4%) | 25 (48.1%) | |
| 3 | 7 (11.5%) | 16 (30.8 %) | |
| Prior PTGBD | 0 (0 %) | 4 (7.7 %) | |
| Prior ERCP (CBD stone removal) | 2 (3.3 %) | 4 (7.7 %) | |
| Preoperative WBC (cell count/μL ≤ SD) | 8662.0 ± 4472.9 | 10063.1 ± 4353.1 | .229 |
| Preoperative CRP, mg/dL ≤ SD | 0.9 ± 1.3 | 7.7 ± 8.8 | .003 |
| Duration of Symptom | ≤.001 | ||
| ≤72 hours | 57 (93.4%) | 17 (35.4 %) | |
| ≥72 hours | 4 (6.6%) | 31 (64.6 %) | |
| Severity grade | ≤.001 | ||
| TG18, grade I | 56 (91.8 %) | 9 (17.3 %) | |
| TG18, grade II | 5 (8.2 %) | 39 (75.0 %) | |
| TG18, grade III | 0 (0 %) | 4 (7.7 %) |
ASA, American Society of Anaesthesiologists physical status; BMI, Body mass index; CBD, Common bile duct; CRP, C-reactive protein; ERCP, Endoscopic retrograde cholangiopancreatography; PTGBD, Percutaneous gallbaldder drainage; SD, Standard deviation; SILC, single incision laparoscopic cholecystectomy; TG18, Tokyo Guidelines for the Management of Acute Cholangitis and Cholecystitis 2018; WBC, white blood cell counts.
*Excepting four patients who received prior PTGBD.
Perioperative Outcomes
| Pure SILC | SILC with Additional Port | |
|---|---|---|
| No. Additional ports | ||
| One | 43 (82.7 %) | |
| Two | 9 (17.3 %) | |
| Open conversion | 0 (0 %) | 0 (0 %) |
| Combined procedure | 0 (0 %) | 3 (5.7%) |
| Primary closure of cholecystoduodenal fistula | 1 (1.9 %) | |
| Appendectomy | 2 (3.8 %) | |
| Operative time, min ± SD, (range) | 45.0 ± 10.0 (30–65) | 83.3 ± 51.1 (35–265) |
| Hospital stay, day ± SD, (range) | 3.7 ± 1.3 (2–8) | 5.9 ± 2.5 (3–17) |
| Intra-operative event | 0 (0 %) | 6 (11.5 %) |
| Bile leakage (liver cut surface) | 3 (5.8 %) | |
| Bile leakage at CBD | 3 (5.8 %) | |
| Rt. Hepatic artery injury | 1 (1.9 %) | |
| Postoperative complications | 0 (0 %) | 3 (5.7%) |
| Wound complication | 1 (1.9 %) | |
| Bile leakage | 2 (3.8 %) | |
| Reoperation | 0 (0 %) | 0 (0%) |
| Mortality | 0 (0 %) | 0 (0%) |
CBD, common bile duct; LFT, liver function test; SD, Standard deviation; SILC, Single-incision laparoscopic cholecystectomy.
Combined bile leakage from liver surface and CBD in one patient.
Comparison of Groups with Bile Duct Injury and without Bile Duct Injury of Patients who Required Additional Ports
| Group with BD Injury | Group without BD Injury | ||
|---|---|---|---|
| Strasberg classification | |||
| Type A | 3 | ||
| Type D | 2 | ||
| Combined type A and D | 1 | ||
| Sex | .243 | ||
| Male | 5 | 27 | |
| Female | 1 | 19 | |
| Age | .058 | ||
| <70 years | 6 | 28 | |
| >70 years | 0 | 18 | |
| Timing of operation after symptom onset, min ± SD | 510.5 ± 590.5 | 116.4 ± 75.6 | <0.001 |
| Severity grade according to TG18 | .323 | ||
| I | 0 | 9 | |
| II | 6 | 33 | |
| III | 0 | 4 | |
| ASA score | .163 | ||
| 1 | 0 | 11 | |
| 2 | 5 | 20 | |
| 3 | 1 | 15 | |
| BMI, ± SD (kg/m2) | 24.9 ± 3.2 | 24.9 ± 3.2 | .964 |
| WBC count, ± SD (cell count/μL) | 10675.0 ± 2182.6 | 9983.3 ± 4570.6 | .718 |
| CRP, ± SD (mg/dL) | 4.1 ± 6.9 | 8.1 ± 9.0 | .338 |
ASA, American Society of Anaesthesiologists physical status; BD, Bile duct; BMI, Body mass index; CRP, C reactive protein; SD, Standard deviation; TG18, Tokyo Guidelines for the Management of Acute Cholangitis and Cholecystitis 2018; WBC, White blood cell count.
T-test.
Fisher's exact test.